Home Empe Diagnostics

Empe Diagnostics

Empe Diagnostics

Empe Diagnostics
Category
Business Description
EMPE Diagnostics AB, Sweden has developed mfloDx® technology that can rapidly detect the TB causing bacteria and its drug-resistance profiles in less than 3 hours, directly from patients’ sputum samples. The mfloDx® is a technology platform that is customizable to detect any DNA or RNA transcripts. Presently, we are releasing single-use diagnostic test kits for TB and expand our portfolio to sexually transmitted diseases.
Based in
Solna
Tags
Biotechnology, Health Diagnostics, Medical Device, Pharmaceutical
Total Funding
Above €25 million
Founded
2015
Website
https://www.empediagnostics.com/

Articles about Empe Diagnostics:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as Empe Diagnostics? We're happy to assist you with our Startup Sourcing service.